Investor Relations

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Vital Therapies Plans Phase III Trials for September
Vital Therapies Plans Phase III Trials for September
View HTML
Toggle Summary Liver device helps man survive until transplant
Liver device helps man survive until transplant
View HTML
Toggle Summary Doctors test latest attempt at artificial liver
Doctors test latest attempt at artificial liver
View HTML
Toggle Summary ELAD® Liver Support System Study Initiated at Multiple U.S. Center
Program Expands on Successful Results from prior U.S., U.K. and China Trials
View HTML
Toggle Summary Vital Therapies™ Announces Presentation of ELAD® "Artificial Liver" Data at American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting.
Boston, MA., Nov. 7, 2007 /PRNewswire/- /- Vital Therapies, Inc. (VTI), announced today data from two studies of the company’s ELAD® (Extracorporeal Liver Assist Device) System were presented at the 2007 American Association for the Study of Liver Diseases (AASLD) Annual Meeting, which
View HTML